What To Know about Low White Blood Cell Count (Neutropenia)
A low white blood cell count is called neutropenia and occurs when your body does not have enough white blood cells to ...
Targeted Oncology3 天
Borges Examines Approach to ER+, HER2 0 mBC With PIK3CA Mutation
During a Case-Based Roundtable® event, Virginia F. Borges, MD, MMSc, discussed treatment selection for a patient with ER+, ...
Business Wire12 天
ENHERTU ® (fam-trastuzumab deruxtecan-nxki) showed substantial clinical activity in ...
WILMINGTON, Del.--(BUSINESS WIRE)--Results from the DESTINY-Breast12 Phase IIIb/IV trial showed that ENHERTU ® (fam-trastuzumab deruxtecan-nxki) demonstrated substantial overall and intracranial ...
ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic ...
ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic Breast Cancer and Brain Metastases ...
SurvivorNet on MSN7 天
Major New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients ...
The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in combination with an aromatase ...